Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers shares dive on end of weight loss drug shortage

Hims & Hers Health (HIMS) shares nosedive on news from the US Food and Drug Administration (FDA) that the shortage…

Why Hims & Hers Health (HIMS) Shares Are Getting Obliterated Today

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 24% in the afternoon session after U.S. Food and Drug…

Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers

The ruling shows Novo Nordisk’s confidence that the supply of semaglutide will be stable for now.…

Why Hims & Hers Health Stock Is Plummeting Today

The move comes as the S&P 500 lost 1% and the Nasdaq Composite lost 1.3%. Hims & Hers, one…

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

Shares of Hims & Hers tumble 21% after FDA says semaglutide is no longer in shortage…

Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage

Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage…

Hims & Hers Health (NYSE:HIMS) Stock Surges 162% Despite Broader Market Declines

Hims & Hers Health (NYSE:HIMS) experienced a significant price move of 162% over the last quarter, a notable increase amidst…

Analysts explain why Hims & Hers stock is crashing today By Investing.com

Analysts explain why Hims & Hers stock is crashing today…

Whats Going On With Hims & Hers Health Stock Today? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health acquired a peptide facility to strengthen its U.S. supply chain and meet demand for personalized treatments.…

Hims & Hers - Telemedizin-Spezialist überzeugt dank Adipositas-Präparaten und neuen Heimtests-Angeboten mit attraktiver Wachstumsstory!

Geschäftstreiber: Hims &Hers (HIMS) gehört zu den führenden US-Anbietern im Bereich Telemedizin. Da man über die Plattform auch Beratungen und…

Hims & Hers: A Glorious Opportunity To Trim (Rating Downgrade) (NYSE:HIMS)

Hims & Hers Health, Inc. stock surged 1,000% with strategic growth, but high valuation & short interest suggest taking profits.…

Hims & Hers falls, Novo Nordisk rises after FDA says Ozempic shortage is over

The move means compounding pharmacies like Hims & Hers will have a harder time selling compounding versions of Ozempic....…

Leerink sees potential for ‘reset’ in Hims & Hers with Ozempic shortage ended

Leerink notes that the shortage of Novo Nordisk’s (NVO) semaglutide, marketed as Wegovy and Ozempic, has been resolved according to…

Hims & Hers Crashes 22%--But Its Secret Power Move Could Change Everything

The FDA just slammed the door on its booming weight-loss drug business--but Hims & Hers has a bold new strategy.…

Hims & Hers acquire peptide facility to expand drug manufacturing

Earlier this week, Hims & Hers announced the purchase of an at-home blood-testing company.…

Hims & Hers gains peptide facility; shares tumble on semaglutide shortage end (HIMS:NYSE)

Hims & Hers acquires a peptide facility, but shares fall as FDA says a shortage of semaglutide has come to…

Hims & Hers Health stock falls as FDA ends drug shortage By Investing.com

Hims & Hers Health stock falls as FDA ends drug shortage…

Hims & Hers stock falls as Ozempic shortage ends (HIMS:NYSE)

Hims & Hers Health (HIMS) stock falls as the FDA declares that Novo Nordisks (NVO) weight loss therapies are no…

Novo Nordisk up 6%, Hims & Hers down 15% as FDA says Ozempic shortage over

Shares of Novo Nordisk (NVO) are up 6% in pre-market trading after a FDA drug shortage notice indicated that a…

Hims & Hers acquires U.S.-based peptide facility in California

Hims Hers announced it has acquired a U.S.-based peptide facility based in California. The company said the acquisition will…

Hims Expands Drug Manufacturing With California Peptide Plant Acquisition

Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, including those…

Why Is HIMS Stock Down So Much? Should You Buy?

Hims & Hers stock has plunged after the FDA announced the end of a shortage of weight-loss drugs. Is the…

Bank of America Forecasts Strong Price Appreciation for Hims & Hers Health (NYSE:HIMS) Stock

Bank of America raised their price objective on Hims & Hers Health from $18.00 to $21.00 and gave the company…

Hims & Hers: After A 205% Gain, Downgrading; Options Present An Opportunity

Hims & Hers appears overextended, increasing the likelihood of a pullback in the short term. Click here to see why…

Hims & Hers Health, Inc. (NYSE:HIMS) Insider Soleil Boughton Sells 4,152 Shares

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 4,152 shares of Hims & Hers…

Hims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum Sells 128,127 Shares

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CEO Andrew Dudum sold 128,127 shares of the businesss stock…

Hims & Hers Health (NYSE:HIMS) Trading Down 5.9%

Hims & Hers Health (NYSE:HIMS) Trading Down 5.9% - Should You Sell?…

Recent Insider Transactions at Hims & Hers Health

Hims & Hers Health has seen a series of insider transactions according to recent SEC Form 4 filings. Chief Commercial…

Hims & Hers Acquires US-based Peptide Facility

Hims & Hers Health, Inc., the leading health and wellness platform, today announced an acquisition that will further verticalize the…

Why Hims & Hers Stock Dropped Today

Hims & Hers Health (NYSE: HIMS) tumbled 5.6% through 12:20 p.m. ET Thursday after Bank of America analysts gave mixed…

Hims & Hers Health (HIMS) Upward Trajectory Boosted by Recent Acquisition

Telehealth pioneer Hims Hers Health ($HIMS) stock is soaring, with a 12% gain in recent days and a whopping…

Hims & Hers Health (NYSE:HIMS) Soars 184% As Personalized Wellness Sector Gains Traction

Hims & Hers Health (NYSE:HIMS) recently recorded a staggering 185% increase in its stock price over the last quarter. This…

Trybe Labs, at-home lab testing facility, acquired by Hims & Hers

Kearny-based Sigmund NJ, marketed as Trybe Labs, has been acquired by Hims & Hers —  which is now expanding its…

Hims & Hers Health (NYSE:HIMS) Shares Gap Down

Hims & Hers Health (NYSE:HIMS) Shares Gap Down - Heres What Happened…

Hims & Hers Health (NYSE:HIMS) Given New $21.00 Price Target at Bank of America

Bank of America raised their price objective on shares of Hims & Hers Health from $18.00 to $21.00 and gave…

Hims & Hers price target raised to $21 from $18 at BofA

BofA raised the firm’s price target on Hims Hers to $21 from $18 and keeps an Underperform rating on…

Hims & Hers Health (NYSE:HIMS) Sets New 52-Week High After Analyst Upgrade

Hims & Hers Health (NYSE:HIMS) Reaches New 1-Year High After Analyst Upgrade…

Why Hims & Hers Health, Inc. (HIMS) Went Up On Wednesday?

We recently published a list of 10 Stocks Stand Strong Amid Cautious Market Environment. In this article, we are going…

Why Hims & Hers Health, Inc. (HIMS) Went Up On Wednesday?

We recently published a list of 10 Stocks Stand Strong Amid Cautious Market Environment. In this article, we are going…

Hims & Hers Stock: The Pros And Cons Of The Trybe Acquisition (NYSE:HIMS)

Hims & Hers acquisition of Trybe Labs broadens its treatment range and enhances its competitive edge through increased data collection.…

Hims & Hers Health surges on acquisition for at-home testing

Hims & Hers Health (HIMS) stock gains on news that the company acquired Trybe Labs, which will allow the telehealth…

Hims & Hers Stock Hits Record High on Blood-Testing Lab Acquisition

Key Takeaways Shares of Hims & Hers Health touched a fresh record high in Wednesday trading after the company announced…

Hims & Hers acquires at-home-testing company

The aim is to offer a broader range of personalized treatment options to patients.…

Hims & Hers Health Stock Hits All-Time Highs: Whats Going On? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health Inc (NYSE:HIMS) shares are soaring Wednesday after the company announced plans to introduce at-home lab testing.…

Hims & Hers Health: Spezialist schlägt Giganten im Telemedizinmarkt!

Telemedizin ist ein Feld für Spezialisten – und genau hier spielt Hims & Hers Health seine Stärken aus. Während Kritiker…

Hims & Hers Health: Strategische Expansion in At-Home-Labortests – Cannacord erhöht Kursziel von 38 USD auf 68 USD!

Markterweiterung Heimtests:  Übernahme von Trybe Labs erschließt margenstarke Gesundheitssegmente und stärkt das personalisierte Behandlungsangebot.  Kursziel steigt um fast 80…

Hims & Hers to provide at-home blood testing with new acquisition

The company says it will use blood-testing data to help develop an AI-powered system that will provide “personalized care.”...…

HIMS Stock Rockets on At-Home Blood Test Plans

Hims & Hers Health (HIMS) stock rocketed higher today after the telehealth platform operator announced plans to introduce at-home lab…

Hims & Hers Health (NYSE:HIMS) Hits New 1-Year High on Analyst Upgrade

Hims & Hers Health (NYSE:HIMS) Hits New 52-Week High on Analyst Upgrade…

Why Hims & Hers Health (HIMS) Is Rallying Today

By acquiring Sigmund NJ LLC, known as Trybe Labs, Hims & Hers will be able "to support at-home blood draws…